Member Info for Wisheyedbortum

Just in case anyone has any doubts about the advantages of Affimers over Antibodies, it's well worth watching the "Avacta teach in" video on the website, because even though I am a complete dunce, I could understand why Affimers have such a tremendous future and what a very clever chap Matt Johnson is!

Not only is Dr. Alastair Smith a very clever Guy, He's also shrewd cookie and has been laying very solid foundations on which to build Avacta into an extremely successful group of companies. The funds released by the sale of Optim can only help to grow the Affimer business more quickly and I expect the sp to move in a 2 forward, 1 back, 2 forward trend from now on. The difficult decision for me now is, have I got enough shares?

The sale of Optim was on the cards when we visited the company some time ago, so no surprises there. It will however facilitate the acceleration of the commercialization of the Affirmers which is great news for us shareholders. Onwards and upwards.

Point taken. 125 mil traded altogether, don't remember ever seeing that. Good day though.

Yes, great announcement this morning, but once again there's an "if" and no timescale, however this is still building nicely and as per usual I don't expect much movement in the sp, although how nice it would be to be proved wrong!

I bought back in last week but having listened to the presentation, I feel that much topping up is required in time for the anticipated FDA approval. What an amazing company.

I think that if Avacta had to rely on Optim 2 and Sensitest, I may well have abandon ship, or at least reduced my holding, a while ago, but the Affimers are a whole new ballgame. This is a serious product.

Probably a long term multi bagger, but for the time being, Avacta is so far below the radar (and rightly so) that it hasn't attracted the attention it deserves. It's a bit like an iceberg with the top painted blue. Still, it will be worth the wait.

A very encouraging report this morning. I cannot see the sp remaining sub 1p for much longer.

Cheers suki.

That soon? Lol. Cheers.

Been with Avacta since 2009 and there is enormous potential here, it has just been one hell of a long wait. The news is now presented quarterly with the next one due on the 23rd Jan. ( I think ). I do believe that if the market reacts favourably to the next news, then a gradual rise will be on the cards, so this may be a good entry point although please don't take my word for it. I have visited Avacta and received a very warm welcome and presentation from Alastair Smith, and I left there with great confidence for the future and with the knowledge that, barring some unforeseen catastrophe, my investment is safe and bound to grow. Hope this helps.

I think that today's announcement has answered your question. Things are looking very positive. Thanks for your info WALBROOK.

The only problem that Avacta has is one of underfunding. There is huge potential here but the progress is slow and burning money. IMHO the teach in is a twofold attempt to accelerate this progress by bringing to the attention of serious investors the future of the Affimers market and what it could mean in the way of revenue for AVCT and it's share price, plus, hopefully these investors will report to the press what they have learned which will automatically up the SP or better still have the press at the teach in. The cash call today doesn't seem to have affected the SP which is a good sign that perhaps the issue will be oversubscribed again or may even attract new institutional investors as before ( ie NFU ). I would like to point out again that Alastair Smith is a very shrewd cookie and I am confident that 2014 will be a very good year for Avacta, but having said that, if the teach in does not have the desired effect, a reassessment of my holding in AVCT will be in order.

I am assuming that am in the dog house for the moment, but realistically, one extra test on the Sensipod menu doesn't warrant a 15% rise in the sp and if it has been hyped by newspaper articles that's even worse. I fully expect a retrace because it's the Affirmers that will create the big money and the gradual build up of the consumables for Optim 2 and sensipod that will support the eventual growth of Avacta.

Thanks for the info, it certainly is good news and it's good to see the sp break through the 1p barrier. After all this time it would be very welcome to see a gradual tick up.

No rush, but early 2014 you should consider making a move while the price is this low.

I have no idea why there should be a rise in the sp, maybe it's the MMs just playing with it. This board is usually quiet because we are confident of the company's progress and await what we hope will be its inevitable northward journey. Sorry I can't be more specific but bigger fish frying elsewhere.

Suits me fine.

The Market Makers will only change the price of a share if they think that they can make money out of doing so. With Avacta, there have been very few trades and very little news to encourage trading so there would be no point in changing the sp. Mandatory trading? sorry, no idea.